AzurRx BioPharma Inc
AZRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$22.15M
Close$
$3.56
3.2% upside
Current Fair Value
3.2% upsideUndervalued by 3.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $22.15 Million |
|---|---|
| Enterprise Value | $22.71 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.16 |
| Beta | 1.51 |
| Outstanding Shares | 6,419,222 |
Return
| Return on Equity | -53.47% |
|---|---|
| Return on Assets | -21.48% |
| Return on Invested Capital | -97.62% |
Valuation & Multiples
| P/E Ratio | -0.53 |
|---|---|
| PEG | 0.68 |
| Price to Sales | - |
| Price to Book Ratio | 1.73 |
| Enterprise Value to Revenue | 141.64 |
| Enterprise Value to EBIT | -1.02 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data